Cbl Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
CBL (Casitas B-lineage Lymphoma) encodes a RING-type E3 ubiquitin ligase that serves as a critical negative regulator of receptor tyrosine kinase (RTK) signaling. Originally identified as an oncogene, CBL plays essential roles in neuronal development, synaptic plasticity, and cellular homeostasis. Germline mutations in CBL cause a spectrum of developmental disorders collectively termed CBL syndrome, which includes features of Noonan syndrome and increased risk of myeloproliferative disorders. [1]
| Casitas B-lineage Lymphoma | |
|---|---|
| Gene Symbol | CBL |
| Full Name | Casitas B-lineage Lymphoma |
| Chromosome | 11q23.3 |
| NCBI Gene ID | [867](https://www.ncbi.nlm.nih.gov/gene/867) |
| OMIM | [165360](https://www.omim.org/entry/165360) |
| Ensembl ID | ENSG00000110395 |
| UniProt ID | [P22681](https://www.uniprot.org/uniprot/P22681) |
| Protein Class | RING-type E3 ubiquitin ligase |
| Associated Diseases | CBL Syndrome, Noonan Syndrome-like, Myeloproliferative Disorders |
CBL is a 906-amino acid protein with multiple functional domains:
CBL functions as a RING-type E3 ubiquitin ligase with the following substrate targets:
| Substrate | Function | Disease Relevance |
|---|---|---|
| EGFR | RTK signaling | Cancer |
| FLT3 | Hematopoiesis | Myeloproliferation |
| KIT | Stem cell factor receptor | Mastocytosis |
| VEGFR2 | Angiogenesis | Vascular disorders |
| SRC-family kinases | Signal transduction | Multiple |
CBL mediates multiple types of ubiquitination:
CBL is expressed throughout the central nervous system:
In neurons, CBL localizes to:
CBL negatively regulates RTK signaling through:
At synapses, CBL modulates:
During development, CBL regulates:
Germline CBL mutations cause a multisystem disorder:
| Feature | Frequency | Description |
|---|---|---|
| Developmental delay | 100% | Variable intellectual disability |
| Facial dysmorphism | 90% | Characteristic Noonan-like features |
| Cardiac defects | 70% | Pulmonic stenosis, septal defects |
| Cryptorchidism | 60% | Male genital anomalies |
| Hypotonia | 50% | Neonatal muscle weakness |
| Myeloproliferation | 40% | Juvenile myelomonocytic leukemia |
| Lentigines | 35% | Multiple nevi, LEOPARD features |
CBL acts as a tumor suppressor:
CBL mutations lead to:
CBL is a critical E3 ubiquitin ligase regulating receptor tyrosine kinase signaling in neurons and other cell types. While primarily known for its role in cancer and developmental disorders, CBL dysfunction can impact synaptic plasticity and neuronal homeostasis. Understanding CBL biology provides insights into neurodevelopmental disorders and potential therapeutic strategies.
Cbl Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cbl Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Expression data for CBL in the human brain can be explored through the following Allen Brain Atlas resources: